1. Home
  2. Analysis
  3. Verapamil-hydrochloride
  4. Olopatadine-hydrochloride

Verapamil hydrochloride and Olopatadine hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Verapamil hydrochloride and Olopatadine hydrochloride. Common interactions include blood pressure decreased among females and cardiac failure acute among males.

The phase IV clinical study analyzes what interactions people who take Verapamil hydrochloride and Olopatadine hydrochloride have. It is created by eHealthMe based on reports of 10 people who take Verapamil hydrochloride and Olopatadine hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

10 people who take Verapamil hydrochloride and Olopatadine hydrochloride together, and have interactions are studied.

What is Verapamil hydrochloride?

Verapamil hydrochloride has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,613 Verapamil hydrochloride users for its effectiveness, alternative drugs and more.

What is Olopatadine hydrochloride?

Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. eHealthMe is studying from 3,777 Olopatadine hydrochloride users for its effectiveness, alternative drugs and more.

Number of Verapamil hydrochloride and Olopatadine hydrochloride reports submitted per year:

Verapamil hydrochloride and Olopatadine hydrochloride drug interactions.

Common Verapamil Hydrochloride and Olopatadine Hydrochloride drug interactions by gender *:

female:

  1. Blood pressure decreased
  2. Dehydration
  3. Decreased appetite
  4. Purulence
  5. Skin erosion
  6. Skin ulcer
  7. Thermal burn
  8. Renal failure acute
  9. Abdominal distension
  10. Abdominal pain upper

male:

  1. Cardiac failure acute
  2. Pneumonia
  3. Sepsis
  4. Anal abscess
  5. Contusion
  6. Headache
  7. Injection site abscess
  8. Lumbar spinal stenosis
  9. Scrotal abscess
  10. Thrombotic cerebral infarction

Common Verapamil Hydrochloride and Olopatadine Hydrochloride drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Abdominal pain upper
  3. Adverse drug reaction
  4. Amylase increased
  5. Anuria
  6. Asthenia
  7. Asthma
  8. Atrial fibrillation
  9. Blood pressure decreased
  10. Blood pressure immeasurable

50-59:

n/a

60+:

  1. Blood pressure decreased
  2. Cardiac failure acute
  3. Renal failure acute
  4. Conjunctival haemorrhage
  5. Conjunctivitis
  6. General physical condition
  7. International normalised ratio increased
  8. Lung adenocarcinoma
  9. Malignant neoplasm progression
  10. Medical device complication

Common conditions people have *:

  1. Fever: 2 people, 20.00%
  2. Pain: 2 people, 20.00%
  3. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 20.00%
  4. Stress And Anxiety: 1 person, 10.00%
  5. Constipation: 1 person, 10.00%
  6. Full Blood Count Increased: 1 person, 10.00%
  7. Febrile Neutropenia (fever with reduced white blood cells): 1 person, 10.00%
  8. Ear Pain: 1 person, 10.00%
  9. Diabetes: 1 person, 10.00%
  10. Device Related Infection: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Verapamil hydrochloride and Olopatadine hydrochloride?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Verapamil hydrochloride and Olopatadine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Verapamil hydrochloride side effects:

Browse all side effects of Verapamil hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Olopatadine hydrochloride side effects:

Browse all side effects of Olopatadine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Verapamil hydrochloride interactions:

Browse all interactions between Verapamil hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Olopatadine hydrochloride interactions:

Browse all interactions between Olopatadine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride and olopatadine hydrochloride (the active ingredients of Verapamil hydrochloride and Olopatadine hydrochloride, respectively), and Verapamil hydrochloride and Olopatadine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Verapamil hydrochloride and Olopatadine hydrochloride.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.